Literature DB >> 1647306

Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell.

C M Isales1, P Q Barrett, M Brines, W Bollag, H Rasmussen.   

Abstract

The effect of PTH on aldosterone secretion from isolated bovine adrenal glomerulosa cells was examined. PTH binding was autoradiographically localized to the adrenal cortex, suggesting a specific effect. This binding of PTH was displaceable by cold PTH, but not by ACTH. No binding was observed in the adrenal medulla. In addition, PTH was shown to stimulate aldosterone secretion in a dose-dependent manner and to potentiate aldosterone secretion in response to angiotensin-II, such that PTH (10(-9)M) elevated the secretory rate from 58.6 +/- 6.8 to 110.9 +/- 19 pg/min.million cells in the presence of 10 nM angiotensin-II. The magnitude of the synergism between the two hormones depended on the concentrations of PTH and angiotensin-II as well as the time during which aldosterone secretion was measured. Within the first 15 min of stimulation, PTH increased the sensitivity to angiotensin-II, shifting the Ka for activation from 1.0 to 0.3 nM. In contrast, between 30-45 min of angiotensin-II stimulation, PTH elevated the maximal secretory response to angiotensin-II from 109 +/- 3.4 to 219 +/- 13.3 pg/min.million cells. By itself PTH elicited only a small increase in the intracellular Ca2+ concentration, as measured by aequorin luminescence in glomerulosa cells. In cells pretreated with angiotensin-II or 15 mM potassium, the intracellular calcium response to PTH was markedly potentiated. PTH was also found to cause a small increase in the cellular cAMP content. Thus, PTH stimulates aldosterone secretion from adrenal glomerulosa cells, both alone and in combination with angiotensin-II.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647306     DOI: 10.1210/endo-129-1-489

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

2.  PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Authors:  Charles Ginsberg; Timothy E Craven; Michel B Chonchol; Alfred K Cheung; Mark J Sarnak; Walter T Ambrosius; Anthony A Killeen; Kalani L Raphael; Udayan Y Bhatt; Jing Chen; Glenn M Chertow; Barry I Freedman; Suzanne Oparil; Vasilios Papademetriou; Barry M Wall; Clinton B Wright; Joachim H Ix; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

Review 3.  Aging and Adrenal Aldosterone Production.

Authors:  Kazutaka Nanba; Anand Vaidya; William E Rainey
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

Review 4.  Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis.

Authors:  Yiyun Zhang; Bo Feng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio.

Authors:  Xiaoyu Shu; Mei Mei; Linqiang Ma; Zhihong Wang; Shumin Yang; Jinbo Hu; Ying Song; Wenwen He; Ting Luo; Qingfeng Cheng; Yue Wang; Qianna Zhen; Qifu Li
Journal:  J Hum Hypertens       Date:  2018-05-22       Impact factor: 3.012

6.  Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis.

Authors:  A Lasco; A Catalano; N Morabito; A Gaudio; G Basile; A Trifiletti; M Atteritano
Journal:  Osteoporos Int       Date:  2010-03-23       Impact factor: 4.507

7.  Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.

Authors:  Marie-Eve Muller; Valentina Forni Ogna; Marc Maillard; Candice Stoudmann; Carole Zweiacker; Christiane Anex; Grégoire Wuerzner; Michel Burnier; Olivier Bonny
Journal:  Pflugers Arch       Date:  2015-06-20       Impact factor: 3.657

Review 8.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

9.  Hyperparathyroidism in patients with overt and mild primary aldosteronism.

Authors:  Christos Gravvanis; Labrini Papanastasiou; Spiridoula Glycofridi; Nikos Voulgaris; Ernestini Tyfoxylou; Kounadi Theodora; George Piaditis; Αthina Markou
Journal:  Hormones (Athens)       Date:  2021-09-15       Impact factor: 2.885

Review 10.  The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.

Authors:  Ming-Hui Zheng; Fu-Xing-Zi Li; Feng Xu; Xiao Lin; Yi Wang; Qiu-Shuang Xu; Bei Guo; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.